Security key
403783103
GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (GYRE)
CUSIP: 403783103
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 1,787,221
- Total 13F value
- $21,627,571
- Share change
- +76,297
- SEC-reported price per share
- $12.10
- Number of holders
- 38
- Value change
- +$923,657
- Number of buys
- 20
- Number of sells
- 10
- Shares outstanding
- 124,924,768
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
38
Top holders
10
GYRE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
GYRE THERAPEUTICS, INC. SEC filings
GYRE THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 403783103
Recent filing periods:
Ownership snapshot
Top reported holders of GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 0.41%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 0.41%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
0.41%
VANGUARD GROUP INC
0.27%
GEODE CAPITAL MANAGEMENT, LLC
0.24%
CHARLES SCHWAB INVESTMENT MANAGEM...
0.09%
STATE STREET CORP
0.08%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
Company
|
0.41%
|
$6,450,839
514,421 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.27%
|
$4,265,744
340,171 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.24%
|
$3,808,448
303,647 shares
|
— | 30 Sep 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
0.09%
|
$1,425,146
113,648 shares
|
— | 30 Sep 2024 |
| STATE STREET CORP |
13F
Company
|
0.08%
|
$1,310,305
104,490 shares
|
— | 30 Sep 2024 |
| NORTHERN TRUST CORP |
13F
Company
|
0.08%
|
$1,188,265
94,758 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
38
Shares
1,787,221
Rows available
38
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
34
Q4 2024 holders
38
Holder diff
4
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend